Literature DB >> 6300374

Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance.

S Imanishi, M Arita, T Kiyosue, M Aomine.   

Abstract

The effects of various concentrations (1-1000 microM) of SG-75 nitrate or nicorandil) were investigated in action potentials of canine Purkinje fibers with microelectrodes. In normal fibers stimulated at the standard cycle length of 1500 msec, the drug (1-100 microM) produced dose-dependent shortening in action potential duration without changes in the resting potential, the maximum rate of rise of phase 0 and the slope of phase 4 depolarization. The drug-induced percentage of shortening in the action potential duration was more pronounced at lower rates of stimulation and lower external K+ concentrations, but the shortening was unchanged in lower external Na+ concentrations. Depolarizations produced by Ba++ (0.04 mM) and low K+ (less than or equal to 1.35 mM) solution were partially reversed by the drug, whereas there were no effects on the high K+ (5.4-24.7 mM)-induced depolarizations. Stretch-induced depolarization was also partially recovered in the presence of the drug. SG-75 shortened the duration of the slow response produced by isoproterenol (1 microM) in the presence of 24.7 mM K+, with little change in the maximum rate of rise. We concluded that SG-75 increases membrane K+ conductance in cardiac Purkinje fibers probably by modifying ix1 and iK1 channels without changing the slow inward currents and that the effects are not mediated by muscarinic receptors. The computed action potentials indicated that this view was reasonable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300374

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

Review 2.  Electrophysiologic effects of potassium channel openers.

Authors:  W Haverkamp; M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 3.  Pharmacology of the potassium channel openers.

Authors:  G Edwards; A H Weston
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

4.  Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.

Authors:  G Scholtysik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

5.  Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles.

Authors:  M Kojima; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

6.  Effect of the potassium-channel opener nicorandil as an adjunct to cardioplegia on myocardial preservation in isolated rabbit hearts.

Authors:  Y Wang; M Sunamori; T Yoshida
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

7.  A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.

Authors:  S Di Somma; V Liguori; M Petitto; A Carotenuto; D Bokor; O de Divitiis; M de Divitiis
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

8.  Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil.

Authors:  G M Pieper; G J Gross
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

9.  Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome.

Authors:  Sandeep S Hothi; Glyn Thomas; Matthew J Killeen; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2009-05-09       Impact factor: 3.657

10.  Electrophysiologic effects of nicorandil, a new antianginal agent, on action potentials and membrane currents of rabbit atrioventricular node.

Authors:  Y Habuchi; M Nishimura; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.